AzTrials
AzTrials

Critical IllnessNCT02897713

Feasibility, Safety, and Outcomes of Intensive Enteral Nutrition in Patients With Mechanical Ventilation

A study testing intensive enteral nutrition and routine enteral nutrition in people with Critical Illness, run by Shanghai Zhongshan Hospital at 1 site in China.

Suspended

Paused. Enrolment is on hold for now and may resume.

Official record
Search all trials

Trial summary

Patients with mechanical ventilation are in risk of malnutrition, which could lead to worse outcome. According to guidelines released from authority organizations, enteral nutrition (EN) should be prior approach for critically ill patients. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Critical Illness
What is being tested?
intensive enteral nutrition and routine enteral nutrition
Could I receive a placebo?
No, everyone receives an active treatment
How many people
400 participants
Where
1 siteChina
Study dates
Nov 2016to Jun 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • predicted time of mechanical ventilation more than 48 hours

Who cannot join

  • no enteral nutrition pathway
  • refuse to informal consent
  • surgeon refuse the protocol
  • palliative care

Trial locations and contacts

1 site in 1 country.

China1 site
  • 180 Fenglin Road

    Shanghai, 20032

Other trials in China

About this study

Official title: Feasibility, Safety and Outcomes of Intensive Enteral Nutrition in Mechanical-ventilated Patients: a Multicenter, Parallel Randomized Trial

Patients with mechanical ventilation are in risk of malnutrition, which could lead to worse outcome. According to guidelines released from authority organizations, enteral nutrition (EN) should be prior approach for critically ill patients. However, initiation and delivery of EN during the early period of ICU admission are frequently hampered, which results in underfeeding. The investigators speculate whether an intensive enteral nutrition strategy could reinforce the delivery of EN thereby improving outcomes. In this multi-center, prospective, randomized parallel clinical trial, the investigators aim to assess the feasibility, safety and outcomes of intensive enteral nutrition in mechanical-ventilated patients.

Being tested
intensive enteral nutrition, routine enteral nutrition
Keywords
mechanical ventilation, enteral nutrition, feeding intolerance
Medical subject headings
Critical Illness

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • intensive enteral nutritionOther

    After recruitment, patients should be assessed for EN initiation during first 24 hours after ICU admission. 80% of energy target should be reached within 72 hours.

  • routine enteral nutritionOther

    Attendings decide when and how EN should be administered according to guidelines from academic organizations, such as ESPEN or ASPEN.

Study groups in NCT02897713
Study groupRoleWhat they receive
intensive ENExperimentalIntensive enteral nutrition is to performed until discharge with max during of 7 days
Receives: Other: intensive enteral nutrition
routine ENActive comparatorRoutine enteral nutrition is to performed until discharge with max during of 7 days
Receives: Other: routine enteral nutrition

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Incidence rate of hospital-acquired infections

    Hospital-acquired infections include ventilator-associated pneumonia, bloodstream infection, and urinary catheter-associated infection

    Measured: 28 days after ICU admission

Secondary outcomes (6)
  1. mortality of 28 days

    Measured: 28 days after ICU admission

  2. ICU stay

    Measured: from ICU admission to timepoint of patient's discharge or death, up to 12 months

  3. free days of mechanical ventilation

    Measured: during whole ICU stay, up to 12 months

  4. rate of reaching 80% of energy target during 72 hours

    Measured: first 72 hours after ICU admission

  5. EN-associated adverse events

    Measured: during whole ICU stay, up to 12 months

  6. rate of parenteral nutrition delivery

    Measured: during whole ICU stay, up to 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Sep 2016 (estimated)
  2. Study startNov 2016
  3. Primary completionDec 2020 (estimated)
  4. Study completionJun 2021 (estimated)

Why it stopped: Similar study has been published.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
400 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02897713
Sponsor's protocol ID
IEN
Status last verified
May 2020
First submitted
4 Aug 2016
Last updated
27 May 2020
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing intensive enteral nutrition and routine enteral nutrition in people with Critical Illness, run by Shanghai Zhongshan Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: paused, as of the sponsor's last update on 27 May 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Incidence rate of hospital-acquired infections (time frame: 28 days after ICU admission). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 May 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in